Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

The Annurca apple supplement significantly improved hair growth in people with hair loss.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Ichthyosis with confetti is a genetic skin disorder with consistent ectodermal malformations and various KRT10 gene mutations.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

New eco-friendly method strengthens and sets hair using light and causes less damage.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

The new near-infrared LED device improves skin and hair with no side effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Crisaborole may help regrow hair in children with alopecia areata.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.